CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Norda ASA Company Snapshot
Norda ASA operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Norda ASA with three other pharmaceutical manufacturers in Europe: Dbv Technologies of France (2016 sales of 9.08 million Euro [US$10.69 million] of which 100% was Research & Development), Swedencare AB (publ) of Sweden (53.72 million Swedish Kronor [US$6.32 million] ), and Biotec Pharmacon ASA (71.90 million Norwegian Kroner [US$8.58 million] ).

Sales Analysis. Norda ASA reported sales of NOK 75.81 million (US$9.04 million) for the year ending December of 2016. This represents an increase of 95.6% versus 2015, when the company's sales were NOK 38.76 million. This was the third consecutive year of growth at Norda ASA.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Norda ASA
  Stock Performance Chart for Norda ASA
 
  Stock Data: Recent Stock Performance:
  Current Price (12/5/2017): 18.00
(Figures in Norwegian Kroner)
1 Week n/a   13 Weeks 5.9%  
4 Weeks n/a   52 Weeks n/a  
 
Norda ASA Key Data:
  Ticker: NORD Country: Norway
  Exchanges: OSL Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 75,807,652
(Year Ending Jan 2017).
Employees:
  Currency: Norwegian Kroner Market Cap: 89,826,606
  Fiscal Yr Ends: December Shares Outstanding: 4,990,367
  Share Type: Ordinaere Aksje Closely Held Shares: 2,259,375
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.